Followers | 28 |
Posts | 4308 |
Boards Moderated | 1 |
Alias Born | 09/22/2006 |
Wednesday, February 24, 2021 9:19:32 AM
The more you know, the less you don't know.
Recent ARGX News
- argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease • GlobeNewswire Inc. • 04/16/2024 05:00:00 AM
- argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease • GlobeNewswire Inc. • 03/27/2024 06:00:00 AM
- argenx Announces Annual General Meeting of Shareholders on May 7, 2024 • GlobeNewswire Inc. • 03/26/2024 08:00:00 PM
- argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia • GlobeNewswire Inc. • 03/26/2024 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/08/2024 11:05:13 AM
- argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 03/07/2024 09:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/29/2024 09:04:20 PM
- argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update • GlobeNewswire Inc. • 02/29/2024 06:00:00 AM
- argenx to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 02/26/2024 06:00:00 AM
- argenx to Report Full Year 2023 Financial Results and Fourth Quarter Business Update on February 29, 2024 • GlobeNewswire Inc. • 02/22/2024 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/20/2024 11:06:40 AM
- argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART Hytrulo in Chronic Inflammatory Demyelinating Polyneuropathy • GlobeNewswire Inc. • 02/20/2024 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/18/2024 11:10:34 AM
- argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis • GlobeNewswire Inc. • 01/18/2024 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/08/2024 11:06:54 AM
- argenx Highlights 2024 Strategic Priorities • GlobeNewswire Inc. • 01/08/2024 06:00:00 AM
- argenx to Present at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/02/2024 06:00:00 AM
- Argenx Down Nearly 26%, on Pace for Record Percent Decrease -- Data Talk • Dow Jones News • 12/20/2023 05:37:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/20/2023 11:00:20 AM
- argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus • GlobeNewswire Inc. • 12/20/2023 06:00:00 AM
- Argenx Down Over 10%, On Track for Largest Percent Decrease Since May 2022 -- Data Talk • Dow Jones News • 11/28/2023 04:16:00 PM
- Argenx Shares Down After Vyvgart Study Misses Primary Endpoint • Dow Jones News • 11/28/2023 12:03:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/28/2023 11:01:35 AM
- argenx Reports Topline Results from ADVANCE-SC Study of VYVGART Hytrulo in Primary Immune Thrombocytopenia • GlobeNewswire Inc. • 11/28/2023 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/17/2023 11:01:37 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM